NZeno
New Zealand, NZ · 3 known investors
NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.
Founders & leadership
PT
Paul TanFounder Director & Chief Medical Officer
OG
Olga GarkavenkoFounder Director & Chief Scientific Officer
BE
Bob ElliottFounder & Director (Retired 2020)
PL
Peter LaiChief Executive Officer
Board
HM
Investors · 3
Frequently asked questions
- What does NZeno do?
- NZeno develops porcine (pig) cell-based therapeutics and xenotransplantation technologies, building on work in encapsulated cell therapies and breeding pigs certified as tissue sources for human transplantation. The company operates in the biotechnology and regenerative medicine field.
- Who founded NZeno?
- NZeno was founded by Paul Tan, Olga Garkavenko, Bob Elliott.
- Who are NZeno's investors?
- NZeno's investors include Cure Kids Ventures, NZ Growth Capital Partners, Pacific Channel.
- Where is NZeno headquartered?
- NZeno is headquartered in New Zealand, NZ.